PubMed · 16888652
Drug-target residence time and its implications for lead optimization.
Abstract
Much of drug discovery today is predicated on the concept of selective targeting of particular bioactive macromolecules by low-molecular-mass drugs. The binding of drugs to their macromolecular targets is therefore seen as paramount for pharmacological activity. In vitro assessment of drug-target interactions is classically quantified in terms of binding parameters such as IC(50) or K(d). This article presents an alternative perspective on drug optimization in terms of drug-target binary complex residence time, as quantified by the dissociative half-life of the drug-target binary complex. We describe the potential advantages of long residence time in terms of duration of pharmacological effect and target selectivity.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Robert A Copeland, David L Pompliano, Thomas D Meek. 2006-08-04. Drug-target residence time and its implications for lead optimization.. https://doi.org/10.1038/nrd2082
Cite the original work for its findings. Save a collection to share your selection of sources.